Company / Operating Cash Flow per Share
Stoke Therapeutics, Inc. Operating Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.84
FY2025
5-year range
-$1.82 / $0.84
FY2021-FY2025
Trend
+147.8%
vs FY2024
Sector context
#59 of 212
Health Care
What the data says
At $0.84, Stoke Therapeutics, Inc.'s operating cash flow per share ranks #59 of 212 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 8 years, ranging from $-15.46 in FY2018 to $0.84 in FY2025.
Based on SEC 10-K filings.
0.84 in FY2025.
Improved from $-0.81 to $0.84 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#59 of 212 in Health CareTop 28% of 212This company $0.84 Sector average -$14.72
▼
+105.7% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 147.8% year-over-year.
- Ranks #59 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.84 | +147.8% |
| FY2024 | -$1.77 | -118.5% |
| FY2023 | -$0.81 | +55.4% |
| FY2022 | -$1.81 | +0.4% |
| FY2021 | -$1.82 | -44.4% |
| FY2020 | -$1.26 | +27.0% |
| FY2019 | -$1.73 | +88.8% |
| FY2018 | -$15.46 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026